- Home
- / Dyne Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Dyne Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$30.2
2024-10-29
Market Capitalization
$3.1 B
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| General and administrative expense | 13.4M | 28.7M | 28.2M | 31.4M | 62.5M | 69.9M |
| Operating expense total | 58.6M | 150.0M | 170.9M | 343.4M | 466.5M | |
| EBIT | (58.6M) | (150.0M) | (171.0M) | (242.2M) | (343.9M) | (468.2M) |
| Interest income | 56.0K | 742.0K | 2.9M | 7.6M | 26.9M | 29.9M |
| Net Income | (59.4M) | (149.3M) | (168.1M) | (235.9M) | (317.4M) | (446.2M) |
| EPS | (3.2) | (3.0) | (3.4) | (3.5) |